ZA934199B - Carrier system against gnrh - Google Patents
Carrier system against gnrhInfo
- Publication number
- ZA934199B ZA934199B ZA934199A ZA934199A ZA934199B ZA 934199 B ZA934199 B ZA 934199B ZA 934199 A ZA934199 A ZA 934199A ZA 934199 A ZA934199 A ZA 934199A ZA 934199 B ZA934199 B ZA 934199B
- Authority
- ZA
- South Africa
- Prior art keywords
- carrier system
- gnrh
- system against
- against gnrh
- elicits
- Prior art date
Links
- 101150108262 gnrh1 gene Proteins 0.000 title 1
- NMJREATYWWNIKX-UHFFFAOYSA-N GnRH Chemical compound C1CCC(C(=O)NCC(N)=O)N1C(=O)C(CC(C)C)NC(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)CNC(=O)C(NC(=O)C(CO)NC(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C(CC=1NC=NC=1)NC(=O)C1NC(=O)CC1)CC1=CC=C(O)C=C1 NMJREATYWWNIKX-UHFFFAOYSA-N 0.000 abstract 3
- 101000857870 Squalus acanthias Gonadoliberin Proteins 0.000 abstract 3
- 241000588724 Escherichia coli Species 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 239000000863 peptide conjugate Substances 0.000 abstract 1
- 238000002255 vaccination Methods 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Endocrinology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Gyroscopes (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
- Management, Administration, Business Operations System, And Electronic Commerce (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP92201775 | 1992-06-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA934199B true ZA934199B (en) | 1994-01-10 |
Family
ID=8210697
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA934199A ZA934199B (en) | 1992-06-18 | 1993-06-14 | Carrier system against gnrh |
Country Status (18)
Country | Link |
---|---|
US (2) | US5684145A (ko) |
EP (1) | EP0578293B1 (ko) |
JP (1) | JPH0656696A (ko) |
KR (1) | KR100293025B1 (ko) |
AT (1) | ATE188737T1 (ko) |
AU (1) | AU667715B2 (ko) |
BR (1) | BR9302408A (ko) |
CA (1) | CA2098533C (ko) |
DE (1) | DE69327553T2 (ko) |
DK (1) | DK0578293T3 (ko) |
ES (1) | ES2142848T3 (ko) |
GR (1) | GR3033086T3 (ko) |
HU (1) | HU217096B (ko) |
MX (1) | MX303646A (ko) |
NZ (1) | NZ247907A (ko) |
PT (1) | PT578293E (ko) |
TW (1) | TW240232B (ko) |
ZA (1) | ZA934199B (ko) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8826116D0 (en) * | 1988-11-08 | 1988-12-14 | Danbiosyst Ltd | Adhesive drug delivery composition |
EP0596959B1 (en) * | 1991-07-26 | 2000-03-29 | Commonwealth Scientific And Industrial Research Organisation | Self-adjuvanting peptide vaccine delivery system and production thereof |
US5759551A (en) * | 1993-04-27 | 1998-06-02 | United Biomedical, Inc. | Immunogenic LHRH peptide constructs and synthetic universal immune stimulators for vaccines |
US5688506A (en) * | 1994-01-27 | 1997-11-18 | Aphton Corp. | Immunogens against gonadotropin releasing hormone |
EP0738325A1 (en) * | 1994-01-27 | 1996-10-23 | GX BioSystems A/S | Receptor specific bacterial adhesins and their use |
US6635740B1 (en) * | 1997-03-27 | 2003-10-21 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Ligand/lytic peptide compositions and methods of use |
AUPO776897A0 (en) * | 1997-07-09 | 1997-07-31 | Csl Limited | A method of achieving production gains in livestock and agents useful for same |
US6013770A (en) * | 1997-07-21 | 2000-01-11 | Washington State University | Chimeric contraceptive vaccines |
US6656906B1 (en) * | 1998-05-20 | 2003-12-02 | Trimeris, Inc. | Hybrid polypeptides with enhanced pharmacokinetic properties |
US6258782B1 (en) * | 1998-05-20 | 2001-07-10 | Trimeris, Inc. | Hybrid polypeptides with enhanced pharmacokinetic properties |
AUPP807399A0 (en) | 1999-01-08 | 1999-02-04 | Csl Limited | Improved immunogenic lhrh composition and methods relating thereto |
ES2233284T3 (es) * | 1999-02-17 | 2005-06-16 | Pfizer Products Inc. | Proteinas de fusion que comprenden portadores que pueden inducir una bdoble respuesta inmune. |
CA2407897A1 (en) | 2000-05-05 | 2001-11-15 | Cytos Biotechnology Ag | Molecular antigen arrays and vaccines |
WO2001085763A2 (en) * | 2000-05-05 | 2001-11-15 | Aphton Corporation | Chimeric peptide immunogens their preparation and use |
US7320793B2 (en) | 2001-01-19 | 2008-01-22 | Cytos Biotechnology Ag | Molecular antigen array |
US7115266B2 (en) | 2001-10-05 | 2006-10-03 | Cytos Biotechnology Ag | Angiotensin peptide-carrier conjugates and uses thereof |
CA2462857C (en) * | 2001-10-05 | 2012-01-24 | Cytos Biotechnology Ag | Angiotensin peptide-carrier conjugates and uses thereof |
BR0312792A (pt) | 2002-07-19 | 2005-05-03 | Cytos Biotechnology Ag | Composições de vacinas contendo séries antigênicas de amilóide beta1-6 |
US7537767B2 (en) | 2003-03-26 | 2009-05-26 | Cytis Biotechnology Ag | Melan-A- carrier conjugates |
US7517520B2 (en) | 2003-03-26 | 2009-04-14 | Cytos Biotechnology Ag | Packaging of immunostimulatory oligonucleotides into virus-like particles: method of preparation and use |
GB0424563D0 (en) | 2004-11-05 | 2004-12-08 | Novartis Ag | Organic compounds |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL78775A (en) * | 1985-05-15 | 1992-06-21 | Biotech Australia Pty Ltd | Oral vaccines |
NZ220932A (en) * | 1986-07-03 | 1990-05-28 | Victoria State | Composition comprising an antigenic substance, such as lhrh, conjugated to at least two different carriers and method of immunological castration and spaying |
DE3783425T2 (de) * | 1986-10-13 | 1993-05-13 | Solvay | Mikroorganismen, die fremdproteinenthaltende pili tragen, isolierte pili, verfahren zur ausscheidung von proteinen in verwendung dieser pili und deren nutzen. |
WO1988008430A1 (en) * | 1987-04-27 | 1988-11-03 | Commonwealth Scientific And Industrial Research Or | Peptide production by protein engineering |
ES2042718T3 (es) * | 1987-10-26 | 1993-12-16 | Akzo Nv | Procedimiento para la preparacion de una vacuna para proteger aves de corral contra septicemia producida por e. coli. |
US5036047A (en) * | 1988-09-29 | 1991-07-30 | Pitman-Moore, Inc. | Method and composition for preventing conception |
GB8826116D0 (en) * | 1988-11-08 | 1988-12-14 | Danbiosyst Ltd | Adhesive drug delivery composition |
GB2228262B (en) * | 1989-01-25 | 1992-10-07 | Nat Inst Immunology | Antigenic derivative of gnrh |
NL8900726A (nl) * | 1989-03-23 | 1990-10-16 | Stichting Centr Diergeneeskund | Peptide, immunogene samenstelling en vaccin- of geneesmiddelpreparaat; werkwijze voor het immuniseren van een zoogdier tegen lhrh, en werkwijze voor het verbeteren van de vleeskwaliteit van varkens. |
-
1993
- 1993-06-14 ZA ZA934199A patent/ZA934199B/xx unknown
- 1993-06-15 ES ES93201712T patent/ES2142848T3/es not_active Expired - Lifetime
- 1993-06-15 EP EP93201712A patent/EP0578293B1/en not_active Expired - Lifetime
- 1993-06-15 DK DK93201712T patent/DK0578293T3/da active
- 1993-06-15 DE DE69327553T patent/DE69327553T2/de not_active Expired - Fee Related
- 1993-06-15 AT AT93201712T patent/ATE188737T1/de not_active IP Right Cessation
- 1993-06-15 PT PT93201712T patent/PT578293E/pt unknown
- 1993-06-16 NZ NZ247907A patent/NZ247907A/en unknown
- 1993-06-16 CA CA002098533A patent/CA2098533C/en not_active Expired - Fee Related
- 1993-06-17 TW TW082104843A patent/TW240232B/zh active
- 1993-06-17 HU HU9301764A patent/HU217096B/hu not_active IP Right Cessation
- 1993-06-17 KR KR1019930011071A patent/KR100293025B1/ko not_active IP Right Cessation
- 1993-06-17 MX MX303646A patent/MX303646A/es not_active IP Right Cessation
- 1993-06-18 AU AU41343/93A patent/AU667715B2/en not_active Ceased
- 1993-06-18 BR BR9302408A patent/BR9302408A/pt not_active Application Discontinuation
- 1993-06-18 JP JP5172381A patent/JPH0656696A/ja active Pending
-
1995
- 1995-05-30 US US08/453,588 patent/US5684145A/en not_active Expired - Fee Related
- 1995-08-29 US US08/521,079 patent/US6019983A/en not_active Expired - Fee Related
-
2000
- 2000-03-29 GR GR20000400775T patent/GR3033086T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DK0578293T3 (da) | 2000-06-26 |
TW240232B (ko) | 1995-02-11 |
MX303646A (es) | 1994-05-31 |
EP0578293B1 (en) | 2000-01-12 |
PT578293E (pt) | 2000-06-30 |
BR9302408A (pt) | 1994-01-11 |
AU4134393A (en) | 1993-12-23 |
ATE188737T1 (de) | 2000-01-15 |
CA2098533A1 (en) | 1993-12-19 |
HU9301764D0 (en) | 1993-10-28 |
GR3033086T3 (en) | 2000-08-31 |
CA2098533C (en) | 2005-08-16 |
HUT68554A (en) | 1995-06-28 |
US5684145A (en) | 1997-11-04 |
US6019983A (en) | 2000-02-01 |
JPH0656696A (ja) | 1994-03-01 |
KR100293025B1 (ko) | 2001-09-17 |
NZ247907A (en) | 1994-12-22 |
EP0578293A1 (en) | 1994-01-12 |
KR940000115A (ko) | 1994-01-03 |
DE69327553D1 (de) | 2000-02-17 |
AU667715B2 (en) | 1996-04-04 |
HU217096B (hu) | 1999-11-29 |
DE69327553T2 (de) | 2000-08-10 |
ES2142848T3 (es) | 2000-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA934199B (en) | Carrier system against gnrh | |
CA2123612A1 (en) | Hybrid protein between cs from plasmodium and h bsag | |
GB2210557B (en) | Vaccine containing tumor antigens and refined detoxified endotoxin as an adjuvant. | |
AU4399085A (en) | Immunologically active peptides capable of inducing immunization against malaria and genes encoding therefor | |
CA2169071A1 (en) | Methods for modulating the human sexual response | |
GR3029791T3 (en) | Improved immunogenic compositions against human gastrin 17 | |
ZA928162B (en) | Antibodies in immunosuppression. | |
AU1380788A (en) | Synthetic peptide antigens for the detection of hiv-1 infection | |
GR3035198T3 (en) | Medical preparation containing the subunit p40 of interleukin 12. | |
EP0652764A4 (en) | USE OF SYNTHETIC PEPTIDES FOR THE INDUCTION OF TOLERANCE TO SELF-ANTIGEN T AND B CELL EPITOPES. | |
NZ333226A (en) | Immunstimulating lipid formulation | |
GB2228262B (en) | Antigenic derivative of gnrh | |
AU643959B2 (en) | Semisynthetic derivatives with immunomodulation activity, suitable for parenteral and oral administration | |
ES8801126A1 (es) | Un procedimiento para preparar una vacuna para proteger seres humanos contra infeccion por plasmodium falciparum | |
AU2521792A (en) | Chicken anaemia agent vaccine | |
HU9600757D0 (en) | Adjuvant based on colloidal iron compounds | |
MY102249A (en) | Vaccine | |
MX9300883A (es) | Polipeptidos de vacuna. | |
GR3019859T3 (en) | Synthetic vaccine for the specific induction of cytotoxic T-lymphocytes | |
DK665688D0 (da) | Polypeptid | |
IL101639A0 (en) | Recombinant influenza vaccines | |
EP0648124A4 (en) | METHOD FOR STIMULATING THE IMMUNE SYSTEM. | |
ZA893737B (en) | Modulation of the immune response system | |
EP0693936A4 (en) | CLONE PROTEIN OF THE OUTER MEMBRANE OF -i (LEPTOSPIRA) | |
ITFI920071A1 (it) | Antigeni ricombinanti proteici ad aumentata immunogenicita' contenenti il peptide rappresentato dalla sequenza vqgeesndk |